Evaluation of Survival Analysis Models for Predicting Factors Infuencing the Time of Brucellosis Diagnosis

Document Type: Short Communication

Authors

1 MPH Student in Epidemiology, Isfahan University of Medical Sciences, Isfahan, Iran

2 PhD student in Epidemiology, Department of Public Health , Faculty of Health ,Bushehr University of Medical Sciences, Bushehr, Iran

3 Bsc of public health, Isfahan University of Medical Sciences, Fereydunshahr health center, Isfahan, Iran

Abstract

Background:Brucellosis or Malta fever is one of the most common zoonotic diseases in the world. In addition to causing human suffering and dire economic impact on animals, due to the high prevalence of Brucellosis in the western regions of Isfahan province, this study aimed to analyze effective factors in the time of Brucellosis diagnosis using parametric and semi-parametric models and to evaluate the goodness of fit of these models.
Methods:This historical cohort study, 412 patients with Brucellosis in Fereydunshahr, Iran who had referred to hospital, rural & urban health centers and physicians' private clinics in Fereydunshahr between 2006 and 2016 were recruited through census sampling. The failure (or event) in this study, was diagnosis of Brucellosis based on positive immunologic tests (2-ME test ≥1:40 and Wright serology ≥1:80). In order to eliminate  confounding variables, effective factors of the time of Brucellosis diagnosis were determined using univariate (P≤0.20) and multivariable (P<0.05) analysis according to Cox semi-parametric model and five parametric models (weibull, exponential, log-logic, log-normal and gompertz) and the best fitted model was identified. Data were analyzed using R software version 3.2.3.
Results: According to the results of this study, occupation (farmer and livestock breeder), place of residence (urban), having a history of direct contact with livestock, simultaneous infection in other family members, and the newness of the disease (vs. recurrence) were identified as predictors of early detection of the disease. 
Conclusion: Despite the researchers' tendency to use Cox method in survival analysis, in this study, according to AIC, “Gopmpertz” parametric model was recognized as the best fitted regression model in the analysis of the effective factors in the definitive time of Brucellosis diagnosis.

 
 

Keywords


  1. Adesokan HK, Alabi PI, Ogundipe MA. Prevalence and predictors of risk factors for Brucellosis transmission by meat handlers and traditional healers' risk practices in Ibadan, Nigeria. J Prev Med Hyg 2016; 57(3):E164-71.
  2. Golshani M, Buozari S. A review of brucellosis in Iran: epidemiology, risk factors, diagnosis, control, and prevention. Iran Biomed J 2017; 21(6):349-59.
  3. Kargarian Marvasti S, Abolghasemi J, Heydari I, Rimaz S. Effective factors in the time of development of neuropathy in type ii diabetic patients. Iranian Journal of Epidemiology 2017; 13(2):80-9. [In Persian].
  4. Kargarian-Marvasti S, Rimaz S, Abolghasemi J, Heydari I. Comparing of cox model and parametric models in analysis of effective factors on event time of neuropathy in patients with type 2 diabetes. J Res Med Sci 2017; 22:115.
  5. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000.
  6. Efron B. The efficiency of Cox’s likelihood function for censored data. J Am Stat Assoc 1977; 72(359):557-65.
  7. Lawless JF. Parametric Models in Survival Analysis. In: Armitage P, Colton T. Encyclopedia of Biostatistics. 2nd ed. New York: Wiley; 2005.
  8. Bennett S. Analysis of survival data by the proportional odds model. Statistics in Medicine 1983; 2(2):273-77.
  9. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. 2nd ed. Wiley: New York; 2002.
  10. Oakes D. The asymptotic information in censored survival data. Biometrika 1977; 64(3):441-8.
  11. Rajaeefard A, Moghimi Dehkordi B, Tabatabaee HR, Zeighami B, Safaee A, et al. Applying parametric models for survival analysis of gastric cancer. FEYZ 2009; 13(2):83-8. [In Persian].
  12. Ghadimi M, Mahmoodi M, Mohammad K, Zeraati H, Rasouli M, Sheikhfathollahi M. Family history of the cancer on the survival of the patients with gastrointestinal cancer in northern Iran, using frailty models. BMC Gastroenterol 2011; 11:104.
  13. Viswanathan V, Tilak P, Kumpatla S. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study. Indian J Med Res 2012; 136(1):46-53.
  14. Gregori D, Petrinco M, Bo S, Desideri A, Merletti F, Pagano E. Regression models for analyzing costs and their determinants in health care: an introductory review. Int J Qual Health Care 2011; 23(3):331-41.
  15. Gomez MC, Nieto JA, Rosa C, Geijo P, Escribano MA, Munoz A, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol 2008; 15(6):1031-3.
  16. Gavazzi G, Prigent D, Baudet JM, Banoita S, Daoud W. Epidemiologic aspects of 42 cases of human brucellosis in the Republic of Djibouti. Med Trop (Mars) 1997; 57(4):365-8.
  17. Honarvar B, Moghadami M, Lankarani KB, Davarpanah MA, Ataolahi M, Farbod A, et al. Brucellosis as a neglected disease in a neglected population: a seroepidemiological study of migratory nomads in the Fars province of Iran. Epidemiol Infect 2017; 145(3):491-7.
  18. Gooya MM, Ahmadnia H, Ghotbi M, Rahimi F, Pezeshki Z. A Comprehensive Guide to the Infectious Disease Care System for Family Physicians. Ministry of Health, Treatment and Medical Training Communicable Disease Management Center 2012; 1:153-62.
  19. Colmenero JD, Reguera JM, Martos F, Sanchez-De-Mora D, Delgado M, Causse M, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996; 75(4):195-211.
  20. Eales KM, Norton RE, Ketheesan N. Brucellosis in northern Australia. Am J Trop Med Hyg 2010; 83(4):876-8.
  21. Ahmadi A, Mobasheri M, Hashemi-Nazari SS, Baradaran A, Choobini ZM. Prevalence of hypertension and type 2 diabetes mellitus in patients with colorectal cancer and their median survival time: a cohort study. J Res Med Sci 2014; 19(9):850-4.
  22. Klein JP, Moeschberger LM. Survival Analysis: Techniques for Censored and Truncated Data. 2nd ed. New York: Springer. 2005.
  23. Alavi SM, Mugahi S, Nashibi R, Gharkholu S. Brucellosis risk factors in the southwestern province of Khuzestan, Iran. Int J Entric Pathog 2014; 2(1):e15610.
  24. Cash-Goldwasser S, Maze MJ, Rubach MP, Biggs HM, Stoddard RA, Sharples KJ, et al. Risk factors for human brucellosis in Northern Tanzania. Am J Trop Med Hyg 2017; 98(2):598-606.
  25. El-Koumi MA, Afify M, Al-Zahrani SH. A prospective study of brucellosis in children: relative frequency of pancytopenia. Mediterr J Hematol Infect Dis 2013; 5(1):e2013011.
  26. Lacle A, Valero-Juan LF. Diabetes-related lower-extremity amputation incidence and risk factors: a prospective seven-year study in Costa Rica. Rev Panam Salud Publica 2012; 32(3):192-8.
  27. Roshany D, Azadi NA, Esmail-Nasab N, Yaghoubi M. Application of parametric, semiparametric and nonparametric approaches in survival analysis of patients with acute myocardial infarction. Journal of North Khorasan University of Medical Sciences 2012; 3(5):45-51. [In Persian].